With pending regulatory approval for its topical pain medication for the eye, analysts are taking a fond look at Kala Pharmaceuticals. Source: BioSpace

Kitov announced today that its randomized double-blind, placebo-controlled renal function clinical trial for its lead drug candidate, KIT-302, successfully met its primary efficacy endpoint. Source: BioSpace

One of the growing areas in the medical device industry is new approaches to drug delivery. Source: BioSpace

Earlier this month, Pfizer's chairman and CEO, Ian Read, said he was considering selling the company's Consumer Healthcare business, or possibly spinning it off. Source: BioSpace

A look at the best spots for life science jobs globally. Source: BioSpace

AbbVie said its Phase III drug risankizumab is more effective than its own blockbuster drug Humira or J&J's Stelara for psoriasis patients. Source: BioSpace

BlueRock Therapeutics established its corporate headquarters in Cambridge, MA and has appointed two additional senior executive staffers. Source: BioSpace

BioMarin announced that the FDA granted its valoctocogene roxaparvovec for Hemophilia A Breakthrough Therapy Designation. Source: BioSpace

Teva said Lilly’s planned drug would infringe five patents that cover its own migraine drug, which it sought U.S. Food and Drug Administration approval for on Oct. 16. Source: BioSpace

A closer look at the six jobs in life sciences that are currently in high demand. Source: BioSpace